Citations (25)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
N Franklin Adkinson, William E Strauss, Kristine Bernard, Robert F Kaper, Iain C Macdougall & Julie S Krop. (2017) Comparative safety of intravenous Ferumoxytol versus Ferric Carboxymaltose for the Treatment of Iron Deficiency Anemia: rationale and study design of a randomized double-blind study with a focus on acute hypersensitivity reactions. Journal of Blood Medicine 8, pages 155-163.
Read now
Read now
Neville R. Dossabhoy, Steven Turley, Rebecca Gascoyne, Mihaly Tapolyai & Karina Sulaiman. (2014) Safety of total dose iron dextran infusion in geriatric patients with chronic kidney disease and iron deficiency anemia. Renal Failure 36:7, pages 1033-1037.
Read now
Read now
Articles from other publishers (23)
Isabella Guzzo & Meredith A. Atkinson. 2022. Pediatric Nephrology. Pediatric Nephrology
1779
1794
.
Isabella Guzzo & Meredith A. Atkinson. 2020. Pediatric Nephrology. Pediatric Nephrology
1
16
.
Meredith A. Atkinson & Bradley A. Warady. 2021. Pediatric Dialysis. Pediatric Dialysis
609
631
.
Jorge A. Jesus-Silva, Archie Lamplugh, Sameera Dhada, James O. Burton & Sunil Bhandari. (2020) Conversion of haemodialysis patients from iron sucrose to iron isomaltoside: a real-world experience. BMC Nephrology 21:1.
Crossref
Crossref
Meredith A. Atkinson & Bradley A. Warady. (2017) Anemia in chronic kidney disease. Pediatric Nephrology 33:2, pages 227-238.
Crossref
Crossref
Iain C. Macdougall, Naomi V. Dahl, Kristine Bernard, Zhu Li, Alka Batycky & William E. Strauss. (2017) The Ferumoxytol for Anemia of CKD Trial (FACT)—a randomized controlled trial of repeated doses of ferumoxytol or iron sucrose in patients on hemodialysis: background and rationale. BMC Nephrology 18:1.
Crossref
Crossref
Simon D Roger. (2017) Practical considerations for iron therapy in the management of anaemia in patients with chronic kidney disease. Clinical Kidney Journal 10:suppl_1, pages i9-i15.
Crossref
Crossref
Dale Lee, Diane Barsky, Rachel Hughes, Julia Driggers, Nicole Poupard & Maria Mascarenhas. (2017) Evaluation of the safety of iron dextran with parenteral nutrition in the paediatric inpatient setting. Nutrition & Dietetics 74:5, pages 471-475.
Crossref
Crossref
Brendan Smyth, John F. Knight & William G. Herrington. (2016) The rise and rise of randomized clinical evidence in Sub-Saharan Africa. Clinical Kidney Journal 9:6, pages 814-816.
Crossref
Crossref
Bala Waziri, Monica Mabayoje & Babawale Bello. (2016) Comparison of intravenous low molecular weight iron dextran and intravenous iron sucrose for the correction of anaemia in pre-dialysis chronic kidney disease patients: a randomized single-centre study in Nigeria. Clinical Kidney Journal 9:6, pages 817-822.
Crossref
Crossref
Medha Airy, Sreedhar Mandayam, Aya A. Mitani, Tara I. Chang, Victoria Y. Ding, M. Alan Brookhart, Benjamin A. Goldstein & Wolfgang C. Winkelmayer. (2015) Comparative outcomes of predominant facility-level use of ferumoxytol versus other intravenous iron formulations in incident hemodialysis patients. Nephrology Dialysis Transplantation 30:12, pages 2068-2075.
Crossref
Crossref
Karsten Spicher, Susanne Brendler-Schwaab, Christoph Schlösser, Maria Catarinolo, Sören Fütterer, Peter Langguth & Harald Enzmann. (2015) Differences in tissue distribution of iron from various clinically used intravenous iron complexes in fetal avian heart and liver.. Regulatory Toxicology and Pharmacology 73:1, pages 65-72.
Crossref
Crossref
Iain C. Macdougall, William E. Strauss, Justin McLaughlin, Zhu Li, Frank Dellanna & Joachim Hertel. (2014) A Randomized Comparison of Ferumoxytol and Iron Sucrose for Treating Iron Deficiency Anemia in Patients with CKD. Clinical Journal of the American Society of Nephrology 9:4, pages 705-712.
Crossref
Crossref
Brigitte Schiller, Premila Bhat & Amit Sharma. (2014) Safety and Effectiveness of Ferumoxytol in Hemodialysis Patients at 3 Dialysis Chains in the United States Over a 12-Month Period. Clinical Therapeutics 36:1, pages 70-83.
Crossref
Crossref
Louise M. Moist, Stéphan Troyanov, Colin T. White, Lori D. Wazny, Jo-Anne Wilson, Phil McFarlane, Lori Harwood, Manish M. Sood, Steven D. Soroka, Adam Bass & Braden J. Manns. (2013) Canadian Society of Nephrology Commentary on the 2012 KDIGO Clinical Practice Guideline for Anemia in CKD. American Journal of Kidney Diseases 62:5, pages 860-873.
Crossref
Crossref
Hirohito Ichii, Yuichi Masuda, Tania Hassanzadeh, Mateen Saffarian, Sastry Gollapudi & Nosratola D. Vaziri. (2012) Iron Sucrose Impairs Phagocytic Function and Promotes Apoptosis in Polymorphonuclear Leukocytes. American Journal of Nephrology 36:1, pages 50-57.
Crossref
Crossref
Vaijinath S. Kamanna, Shobha H. Ganji, Stanislav Shelkovnikov, Keith Norris & Nosratola D. Vaziri. (2012) Iron Sucrose Promotes Endothelial Injury and Dysfunction and Monocyte Adhesion/Infiltration. American Journal of Nephrology 35:2, pages 114-119.
Crossref
Crossref
Huseyin ATALAY, Yalcin SOLAK, Kadir ACAR, Nilgun GOVEC & Suleyman TURK. (2011) Safety profiles of total dose infusion of low-molecular-weight iron dextran and high-dose iron sucrose in renal patients. Hemodialysis International 15:3, pages 374-378.
Crossref
Crossref
Kathleen Gura, Esther Chang, Ashley Casey & Erin Roach. (2011) Parenteral Iron Therapy in the Pediatric Patient. ICAN: Infant, Child, & Adolescent Nutrition 3:3, pages 145-151.
Crossref
Crossref
Elena Coppol, Jamie Shelly, Stephanie Cheng, Yaman Kaakeh & Brian Shepler. (2017) A Comparative Look at the Safety Profiles of Intravenous Iron Products Used in the Hemodialysis Population. Annals of Pharmacotherapy 45:2, pages 241-247.
Crossref
Crossref
J. E. Toblli, G. Cao, L. Olivieri & M. Angerosa. (2010) Comparison of the renal, cardiovascular and hepatic toxicity data of original intravenous iron compounds. Nephrology Dialysis Transplantation 25:11, pages 3631-3640.
Crossref
Crossref
Diane K. Wysowski, Lynette Swartz, B. Vicky Borders‐Hemphill, Margie R. Goulding & Catherine Dormitzer. (2010) Use of parenteral iron products and serious anaphylactic‐type reactions. American Journal of Hematology 85:9, pages 650-654.
Crossref
Crossref
Smeeta Sinha, Diana Y.Y. Chiu, George Peebles, Shabeer Kolakkat, Elizabeth Lamerton, Sean Fenwick & Philip A. Kalra. (2009) COMPARISON OF INTRAVENOUS IRON SUCROSE VERSUS LOW-MOLECULAR-WEIGHT IRON DEXTRAN IN CHRONIC KIDNEY DISEASE. Journal of Renal Care 35:2, pages 67-73.
Crossref
Crossref